topotecan has been researched along with Bilateral Wilms Tumor in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (66.67) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Acha, T; Bergeron, C; Catania, S; Graf, N; Howell, L; Mavinkurve-Groothuis, AM; Pritchard-Jones, KL; Spreafico, F; Tytgat, GA; van den Heuvel-Eibrink, MM; van Tinteren, H; Vujanic, G | 1 |
| Athanasopoulos, A; Daladimos, T; Karabelis, A; Kosmas, C; Mylonakis, N; Theotikos, E; Tsakonas, G | 2 |
| Huang, J; Kandel, JJ; Kim, ES; Manley, CA; McCrudden, KW; Middlesworth, W; New, T; O'Toole, K; Soffer, SZ; Yamashiro, DJ | 1 |
| Adams, D; Guillot, A; Homans, AC; Iacono, LC; McCune, JS; Stewart, CF | 1 |
| Alvarado, C; Billups, CA; Chintagumpala, M; Coppes, MJ; Daw, NC; Dome, JS; Freeman, BB; Grant, R; Hoffer, FA; Metzger, ML; Mullen, EA; Stewart, CF; Wu, J | 1 |
| Alders, M; Cransberg, K; Loos, WJ; Lugtenberg, RT; van den Heuvel-Eibrink, MM; Wagner, A | 1 |
| Huang, J; Kandel, JJ; Kim, E; Manley, C; Middlesworth, W; Moore, JT; O'Toole, K; Soffer, SZ; Stolar, C; Yamashiro, DJ; Yokoi, A | 1 |
| Huang, J; Kandel, J; Kim, E; Manley, C; Middlesworth, W; Moore, JT; O'Toole, K; Soffer, SZ; Stolar, C; Yamashiro, D; Yokoi, A | 1 |
1 review(s) available for topotecan and Bilateral Wilms Tumor
| Article | Year |
|---|---|
Double high-dose chemotherapy and stem cell transplantation in adult Wilms' tumor.
Topics: Adult; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carboplatin; Cyclophosphamide; Etoposide; Fatal Outcome; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Melphalan; Paclitaxel; Radiography; Salvage Therapy; Topotecan; Transplantation, Autologous; Wilms Tumor; Young Adult | 2010 |
2 trial(s) available for topotecan and Bilateral Wilms Tumor
| Article | Year |
|---|---|
Treatment of relapsed Wilms tumour (WT) patients: experience with topotecan. A report from the SIOP Renal Tumour Study Group (RTSG).
Topics: Adolescent; Child; Child, Preschool; Disease-Free Survival; Female; Follow-Up Studies; Humans; Infant; Kidney Neoplasms; Male; Neoplasm Recurrence, Local; Retrospective Studies; Risk Factors; Survival Rate; Topoisomerase I Inhibitors; Topotecan; Wilms Tumor | 2015 |
Topotecan is active against Wilms' tumor: results of a multi-institutional phase II study.
Topics: Area Under Curve; Child; Child, Preschool; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Immunohistochemistry; Infusions, Intravenous; Kidney Neoplasms; Male; Maximum Tolerated Dose; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Risk Assessment; Survival Analysis; Topotecan; Treatment Outcome; Wilms Tumor | 2007 |
6 other study(ies) available for topotecan and Bilateral Wilms Tumor
| Article | Year |
|---|---|
Second high-dose chemotherapy intensification followed by hematopoietic stem cell transplantation applying a novel high-dose topotecan-based regimen in an adult Wilms' tumor patient: case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Cyclophosphamide; Dose-Response Relationship, Drug; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Kidney Neoplasms; Male; Melphalan; Nephrectomy; Topotecan; Wilms Tumor; Young Adult | 2011 |
Vascular remodeling marks tumors that recur during chronic suppression of angiogenesis.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Ephrin-B2; Female; Fluorescein Angiography; Fluorescent Antibody Technique, Indirect; Humans; In Situ Hybridization; Mice; Mice, Nude; Microscopy, Fluorescence; Neoplasm Proteins; Neoplasm Recurrence, Local; Neovascularization, Pathologic; Proto-Oncogene Proteins c-sis; Receptor, Platelet-Derived Growth Factor beta; Topotecan; Transplantation, Heterologous; Vascular Endothelial Growth Factor A; Wilms Tumor | 2004 |
Topotecan disposition in an anephric child.
Topics: Antineoplastic Agents; Child; Cyclophosphamide; Enzyme Inhibitors; Humans; Kidney Neoplasms; Male; Renal Dialysis; Renal Insufficiency; Topoisomerase I Inhibitors; Topotecan; Wilms Tumor | 2004 |
Topotecan distribution in an anephric infant with therapy-resistant bilateral Wilms tumor with a novel germline WT1 gene mutation.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Combined Modality Therapy; Dactinomycin; DNA, Neoplasm; Doxorubicin; Drug Resistance, Neoplasm; Exons; Female; Frameshift Mutation; Genes, Wilms Tumor; Germ-Line Mutation; Humans; Infant; Kidney Neoplasms; Loss of Heterozygosity; Metabolic Clearance Rate; Nephrectomy; Peritoneal Dialysis; Polymorphism, Single Nucleotide; RNA Splice Sites; Sequence Analysis, DNA; Topotecan; Vincristine; Wilms Tumor | 2008 |
Combination antiangiogenic therapy: increased efficacy in a murine model of Wilms tumor.
Topics: Animals; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Disease Models, Animal; Endothelial Growth Factors; In Situ Nick-End Labeling; Injections, Intraperitoneal; Kidney Neoplasms; Lymphokines; Mice; Mice, Nude; Neoplasm Transplantation; Neovascularization, Pathologic; Reference Values; Sensitivity and Specificity; Survival Rate; Topotecan; Treatment Outcome; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors; Wilms Tumor | 2001 |
Novel use of an established agent: Topotecan is anti-angiogenic in experimental Wilms tumor.
Topics: Angiogenesis Inhibitors; Animals; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Mice; Mice, Nude; Neovascularization, Pathologic; Topotecan; Wilms Tumor | 2001 |